Skip to main content
    E

    Evaxion Biotech AS (EVAX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.77
    +0.03 (+1.09%)

    Market Cap: $25.27M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    Evaxion Biotech AS (EVAX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Evaxion Biotech AS are CEL-SCI (CVM), Edesa Biotech (EDSA) and INmune Bio (INMB). By market cap, Evaxion Biotech AS ranks 10th of the 13 companies on this page; ImageneBio (IMA) is the largest at $43.22M.

    Peer Comparison

    EVAX's ROIC of -79.5% is above the peer median of -102.8%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Evaxion Biotech AS (EVAX)$25.27MN/A0.2x-115.5%-79.5%-100.0%0.00%
    CEL-SCI Corp (CVM)$22.51MN/AN/A0.0%-109.0%-62.7%0.00%
    Edesa Biotech Inc (EDSA)$26.21MN/AN/A0.0%N/A-99.9%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    Elicio Therapeutics Inc. (ELTX)$42.46MN/AN/A0.0%-96.6%0.0%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Estrella Immunopharma Inc. (ESLA)$22.36MN/AN/A0.0%N/A0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Context Therapeutics Inc (CNTX)$16.61MN/AN/A0.0%N/A0.0%0.00%
    Immutep Ltd ADR (IMMP)$25.64MN/A2.2x0.0%N/A633.0%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    Veru Inc (VERU)$35.64MN/AN/A0.0%N/A18.3%0.00%
    Peer median$27.97MN/A2.2x0.0%-102.8%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Evaxion Biotech AS, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    CEL-SCI Corp (CVM)
    CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases.
    CVM competitors
    Edesa Biotech Inc (EDSA)
    Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development...
    EDSA competitors
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    Elicio Therapeutics Inc. (ELTX)
    Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment.
    ELTX competitors
    NextCure Inc (NXTC)
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Estrella Immunopharma Inc. (ESLA)
    Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States.
    ESLA competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Context Therapeutics Inc (CNTX)
    Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid...
    CNTX competitors
    Immutep Ltd ADR (IMMP)
    Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates.
    Instil Bio Inc. (TIL)
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors
    Veru Inc (VERU)
    Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers.
    VERU competitors

    Frequently Asked Questions About EVAX

    Who are Evaxion Biotech AS' main competitors?

    The companies most similar to Evaxion Biotech AS include CEL-SCI (CVM), Edesa Biotech (EDSA), INmune Bio (INMB), Elicio Therapeutics (ELTX) and NextCure (NXTC), listed from the closest match.

    Who is Evaxion Biotech AS' biggest competitor?

    ImageneBio (IMA) is the largest of the similar companies at $43.22M; CEL-SCI (CVM) is the closest match by business profile, size, sector and industry.

    How does EVAX stock compare with its competitors?

    EVAX's P/S is 0.2x against a peer median of 2.2x; its net margin is -115.5% against a peer median of 0.0%.

    Which of Evaxion Biotech AS' competitors pays a higher dividend?

    Evaxion Biotech AS pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Evaxion Biotech AS bigger than its competitors?

    No. Evaxion Biotech AS is 10th by market cap among the 13 companies on this page; the largest is ImageneBio (IMA) at $43.22M.